Study identifier:D0110C00009
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Randomised, Double-Blind, Phase-I, Pharmacodynamic Study to Assess the Effect of Pre-Surgical Treatment with Multiple Doses of AZD5438 or Placebo on Cell Proliferation in Post-Menopausal Women with Previosly Untreated Breast Cancer
solid tumour
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|